4th International Conference of Korean Movement Disorder Society

December 1 (Fri) - 2 (Sat) , 2023
BEXCO, Busan, Korea

Innovations for Clinical Practice in Movement Disorder


PO-0001 Bulging Eye and Upward Gaze Palsy: A Clue to Diagnose Spinocerebellar Ataxia Type 3 Yue Hui LAU Malaysia
PO-0002 Early Onset and Rapid Progression in a Spinocerebellar Ataxia 3 (SCA3) Patient Aulia Putri AYU Indonesia
PO-0003 A Case of Ataxia Telangiectasia Presenting as Slowly Progressing Dystonia and Dystonic Tremor Bora JIN Korea
PO-0004 Hypomyelinating Leukodystrophies Presenting as Movement Disorders Neha PANDITA India
PO-0005 Unusual Presentation in Normal Pressure Hydrocephalus: A Combination of Frontal and Cerebellar Ataxia Myun KIM Korea
PO-0006 Acquired Cerebellar Ataxia Associated with Anti-recoverin Antibodies after COVID-19 Vaccination Kyung Joon JO Korea
PO-0007 Cerebellar Ataxia due to Paraneoplastic Cerebellar Degeneration Mediated by Anti-Yo Antibody Bon Gook KOO Korea
PO-0008 The Impact of Physiotherapy on Cerebral Palsy Ataxia Children in Indonesia: A Literature Review Rinita ISTIQOMAH Indonesia
PO-0009 The Role and Contribution of Technological Innovation in Spinocerebellar Ataxia Treatment Fitri KURNIA Indonesia
PO-0010 Is CAG Repeat Length a Predictor of Gene Expression Regulating Mitochondrial Function among Patients with Spinocerebellar Ataxia 12? Sabbir ANSARI India
PO-0011 Upper Limb Reaching Kinematics in Patients with Spinocerebellar Ataxia Type 12 (SCA12) Using a Novel Marker-less Motion Tracking System Asit Baran BAYEN India
Basic Sciences
PO-0012 Neuro-modulatory Activity of Naringenin in Rotenone-induced Neurotoxicity in Mice Model of Parkinson’s Disease via Suppressing NF-κB Pathway Vikas KUMAR India
PO-0013 Identification of 5-phenylindazoles as Potential Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors and Degraders for Parkinson’s Disease-associated LRRK2 by Computational and In Vitro Approaches Anis Nadhirah KHAIRUL ANUAR Malaysia
PO-0014 Human Induced Pluripotent Stem Cell Lines from the Patients with Parkinson’s Disease Carrying in GBA Mutation Nayeon LEE Korea
PO-0015 Novel PARK7/DJ-1 Frameshift Mutation in a Malay Family Leads to Loss of Expression and Impaired Mitochondrial Function in Patient-derived Fibroblasts Yi Wen TAY Malaysia
PO-0016 Effects of Multi-strain Probiotics on Gut Microbiome and Metabolites in Parkinson’s Disease Jia Wei HOR Malaysia
PO-0017 Distinct Temporal and Spatial Alteration of Immunoproteasome in Parkinson’s Disease Pathogenesis Huu Dat NGUYEN Korea
PO-0018 Role of CREB2 in Mediating Glutamate-Induced Oxidative Cytotoxicity in Hippocampal Neuronal Cells Hye Joung CHOI Korea
PO-0019 Neuroprotective Effect of Crocetin on Iron Induced Oxidative Stress and Cytotoxicity in PC12 Neuronal Cells via Bcl-2/Bax/caspase-3 Signaling Pathways V KUMAR India
PO-0020 Neuroprotective Propensity of Marmelosin Against 6-OHDA-induced Cognitive Impairment and Apoptosis via Upregulation of PI3K/Akt Pathway Ekta YADAV India
PO-0021 Representation of Movement Repertoire in Subthalamic Neural Circuits Using a Markerless 3D Behavioral Tracking System Jung Hwan SHIN Korea
PO-0022 Association of Choroid Plexus Volume with Motor Symptoms and Dopaminergic Degeneration in Parkinson’s Disease Seong Ho JEONG Korea
PO-0023 Association between Choroid Plexus Volume and Cognition in Parkinson’s Disease Seong Ho JEONG Korea
PO-0024 TREM2 in Plasma Extracellular Vesicles and Parkinson’s Disease: A Novel and Reliable Biomarker? Jia-Hung CHEN Taiwan
PO-0025 Comparison of Serum and Plasma Neurofilament Light Chain and Identification of the Relationship between Cortical Thickness and Brain Volume Hyuk Sung KWON Korea
PO-0026 Unraveling Parkinson’s Disease Biomarkers through a Bibliometric Analysis in the Scopus Database (2001-2023)  Rian Ka PRAJA Indonesia
PO-0027 The Role of Plasma Neurofilament Light Chain (Nfl) Levels as A Biomarker for Disease Severity and Progression in Parkinson Disease Roland HELMIZAR Indonesia
PO-0028 An In-silico Analysis of Corosolic Acid’s Effectiveness against Alzheimer’s Disease Dhananjay YADAV India
PO-0029 Potential Salivary Antioxidant Markers in Parkinson’s Disease Patients Rebecca BANERJEE India
PO-0030 The Diagnostic Ability of Tissue-specific miRNA Signatures in Salivary Gland Tissue for De novo Parkinson’s Disease Patient Ko-Eun CHOI Korea
PO-0031 Unilateral Upper Limb Dystonia Developed during the Course of Primary Hypoparathyroidism Chang-Woo KIM Korea
PO-0032 Efficacy Of Baclofen with Carbamazepine in The Treatment of Meige Syndrome: A Case Report John Paul CRUZ Philippines
PO-0033 A Korean Male with SLC2A1 Gene Mutation Presenting as Early Adulthood Onset Paroxysmal Dystonia: A Case Report of a Rare Disorder Yun Su HWANG Korea
PO-0034 Unilateral Lower Limb Dystonic Tremor with SETD1A Mutation Yoon Seob KIM Korea
PO-0035 Orofacial Spasm Induced by Hypothyroidism: A Case Report Sang-Hun LEE Korea
PO-0036 Long-term Remission of Cervical Dystonia after Botulinum Toxin Injection in a Patient with GNAL Mutation Sang Jin PARK Korea
PO-0037 Evaluation of Cerebral Blood Flow Alterations after Deep Brain Stimulation in Cervical Dystonia Byung-Seok KIM Korea
PO-0038 Bibliometric Analysis of Pharmacological Innovations in Dystonia Therapy Hikmal Nibra TAFTAZANI Indonesia
PO-0039 Differential Influence of the Parieto-motor Network on Motor Cortex Excitability in Writer’s Cramp and Cervical Dystonia Hae-Won SHIN Korea
Genetics and Epidemiology in Movement Disorders
PO-0040 Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease Seong Ho JEONG Korea
PO-0041 Transcriptomic Imputation of Genetic Risk Variants Uncovers Novel Whole-blood Biomarkers of Parkinson’s Disease  Aaron Shengting MAI Singapore
PO-0042 The Relationship between GSK3β Activity and TDP-43 Mediated Neuritis in Neurodegenerative Diseases such as Parkinson’s Disease Changxu CUI Korea
PO-0043 Myoclonic Epilepsy of Unverricht and Lundborg in a 40-Year Old Filipino Woman Kruzette Khloe SOLIJON Philippines
PO-0044 Association of Family History and Polygenic Risk Score with Longitudinal Prognosis in Parkinson’s Disease Mincheol PARK Korea
PO-0045 Mortality of Deep Brain Stimulation and Risk Factors in Patients With Parkinson’s Disease: A National Cohort Study in Korea   Ahro KIM Korea
PO-0046 Phenotypic Heterogeneity in Patients with Mutations in the Mitochondrial Complex I Assembly Gene NDUFAF5 Pin-Shiuan CHEN Taiwan
PO-0047 Experiencing Creutzfeldt–Jakob Disease (CJD) over 15 years at Hallym University Sacred Heart Hospital Myun KIM Korea
PO-0048 Genetically Proven Huntington’s Disease in the Philippines: A Case Series Jao Jarro GARCIA Philippines
PO-0049 Association between Body Mass Index Changes and All-cause Mortality in Parkinson’s Disease Ga Eun NAM Korea
PO-0050 Plasma Glucosylsphingosine as a Reliable Biomarker in GBA-associated Parkinson’s Disease Jin HWANGBO Korea
PO-0051 The Role of Parkin for Neuroprotection in TAF15-induced Proteinopathy Changxu CUI Japan
PO-0052 Causal Effects of Sarcopenia on Risk of Parkinson’s Disease: A Bidirectional Mendelian Randomization Study Young Eun HUH Korea
PO-0053 Frequency and Clinical Characterisation of PRKN-Parkinson’s Disease in Indigenous Patients of North Borneo (Sabah), Malaysia Joshua Chin Ern OOI Malaysia
PO-0054 SNCA A53E Mutation Presenting with Parkinson’s Disease Dementia: The First East Asian Case  Yeo Jun YOON Korea
PO-0055 Epidemiology, Healthcare Burden, and Prescription Patterns of Atypical Parkinsonian Disorders in South Korea: National Health Insurance Service Database Dallah YOO Korea
PO-0056 Trends in Physiotherapy Interventions and Medical Costs for Parkinson’s Disease in South Korea, 2011-2020  Dong-Woo RYU Korea
PO-0057 Novel MYORG Variant in an Indigenous North Bornean Family with Primary Familial Brain Calcification Jack Son WEE Malaysia
Infection-and Immune-mediated Movement Disorders
PO-0058 Parkinsonism Secondary to Cryptococcal Meningitis in an Immunocompetent Person-an Elusive Culprit Ting Yoong TEE Malaysia
PO-0059 Dancing out of Step: A Case of Tuberculous Meningitis Disguised as Childhood Chorea Jao Jarro GARCIA Philippines
PO-0060 Anti-NMDA Receptor Encephalitis Presenting with Dystonia and Psychosis Following Tetanus Vaccination Linda JAFFE United States
PO-0061 COVID-19 Vaccine Related Movement Disorders: A Systematic Review Grace Elysse ANGELES Philippines
PO-0062 Myoclonus and Encephalitis as an Adverse Event mRNA COVID-19 Vaccine Namyoung KIM Korea
PO-0063 Seizure in Autoimmune Encephalitis Mimicking Paroxysmal Kinesigenc Dyskinesia  Yohan JU Korea
PO-0064 Atypical Presentation of Subacute Sclerosing Pan-encephalitis---a Series of 8 Cases Purba BASU India
PO-0065 N-methyl-D-Aspartate Receptor (NMDAR) Antibody Encephalitis in a Young Filipino Adult with Delayed Diagnosis of Ovarian Teratoma with Good Response to Medical Management  Patricia Fleur ANDAYA Philippines
PO-0066 Prediction of Virulence Factors in Streptococcus Pyogenes as PANDAS Disease Pathogen Targeted by Epigallocatechin-3-Gallate (EGCG) : A Bioinformatics Analysis  Gigih PRATAMA Indonesia
PO-0067 Assessing the Influence of Gut Microbiome Publication Trends and Impacts in Relation to Infection and the Manifestation of Immune-mediated Movement Disorders Astrid SAPUTRI Indonesia
Neuroimaging in Movement Disorders
PO-0068 The Hyperintense Globus Pallidus Rim Sign on 7 Tesla MRI is a Novel Diagnostic Biomarker of Neurological Wilson’s Disease Dongning SU China
PO-0069 Differential Role of Regional Enlarged Perivascular Space in Cognition and Neuropsychiatric Burden in
  De novo Parkinson’s Disease
Seokhyun KIM Korea
PO-0070 Imaging 4R Tauopathy and Prediction of Brain Volume Changes by Using 18F-PM-PBB3 (florzolotau, APN-1607) Tau PET Cheng-Hsuan LI Taiwan
PO-0071 Aberrant Brain Hyperperfusion and Motor Dysfunction in Parkinson’s Disease Han Soo YOO Korea
PO-0072 Effect on Amyloid-Beta Positivity with 18F-Florbetaben PET in Parkinson’s Disease Dementia  Inuk SONG Korea
PO-0073 Association between Hippocampal Perfusion, Motor Deficits, and Cognitive Decline in Parkinson’s Disease: An Early-phase 18F-FP-CIT PET Study Seok Jong CHUNG Korea
PO-0074 Caudate Dopamine Loss, Occipital Hypoperfusion, and Dementia Conversion in Parkinson’s Disease: A Dual-phase 18F-FP-CIT PET Study Chan Wook PARK Korea
PO-0075 Functional MRI in REM Sleep Behaviour Disorder – What Can We Learn? Lachlan CHURCHILL Australia
PO-0076 Copper Deposition and Multimodality Brain Imaging Features of Wilson’s Disease from a Taiwanese Cohort Chin-Hsien LIN Taiwan
PO-0077 Longitudinal progression of Non-motor Symptoms in Parkinson Disease and Correlation with Dopamine Transporter Availability Seoyeon KIM Korea
PO-0078 Clinical Changes of Untreated Wilson Disesase: A Case of 11 Year Follow Up Sodam GIL Korea
PO-0079 Two Cases of Kernohan’s Notch Phenomenon Associated with Hemiparkinsonism and Holmes Tremor  Eungseok OH Korea
PO-0080 The Hedgehog-halo Sign; A Novel Glymphatic-based Neuroimaging Biomarker in Normal Pressure Hydrocephalus Jongmok HA Korea
PO-0081 Dissociated Changes in Cortical Functional Connectivity Density in Parkinson’s Disease Han Soo YOO Korea
PO-0082 Fasting Plasma Glucose and Striatal Monoamine Activity in De-novo Parkinson’s Disease Patients Ko-Eun CHOI Korea
Other Movement Disorders
PO-0083 New-onset Tics in a Middle-aged Female Unveiling a Pancreatic Neoplasm Diagnosis Phooi Leng LEAN Malaysia
PO-0084 Normal Pressure Hydrocephalus in a Patient with Multiple System Atrophy-Cerebellar: A Twist of Fate Alyssa Pauline CO Philippines
PO-0085 Epilepsy Induced Tourette Syndrome Wandy MARGO Indonesia
PO-0086 Increased Incidence of Functional Movement Disorders during COVID-19 Pandemic Ajith CHERIAN India
PO-0087 Cerebral Venous Thrombosis Presenting as Action Myoclonus: A Case Report Andre Anthony OSAYAN Philippines
PO-0088 Glutamic Acid Decarboxylase 65 – Related Stiff Person Syndrome: Two Cases from the Philippines Redentor Ii DURANO Philippines
PO-0089 Introducing Spastic Paraplegia Care with Extracorporeal Shock Wave Therapy Eun-Hyeok CHOI Korea
PO-0090 Stiff-person Syndrome: A Rare Case Report Enkhjargal MANJIILAA Mongolia
PO-0091 Clinical Characteristics of Normal Pressure Hydrocephalus Patients Who Retained Longer Decompression Effect Jae-Jung LEE Korea
PO-0092 The Diagnosis and Management of Hemifacial Spasm Patients in a Tertiary Hospital in the Philippines Karina Angela LIPARDO Philippines
PO-0093 Mortality Rate According to Body Mass Index and Physical Exercise of Dementia Patients: National Health Insurance Sharing Service Data 2009-2015 Sanghee YOO Korea
PO-0094 Recurrent Chorea in a Patient with Diabetic Striatopathy : A Case Report Ha Eun NA Korea
PO-0095 Phenotypic Variability Among Siblings with Heterozygous VPS13A Variants Seungmin LEE Korea
PO-0096 Exploring Quantitative Susceptibility Mapping in Wilson’s Disease- A Prospective Cohort Study Aminu ALIYAR India
PO-0097 Joubert Syndrome Presenting with Levodopa Responsive Parkinsonism Jin HWANGBO Korea
PO-0098 Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy Hee-Jung HA Korea
PO-0099 Breast Carcinoma Presenting with Stiff-limb Syndrome in a 65-year-old Woman Alfand Marl DY CLOSAS Philippines
PO-0100 Is the Intracortical Inhibitory Circuit Affected in Patients with Functional Gait Disorders? Sattwika BANERJEE India
PO-0101 KCNJ3 as a Potential Novel Gene for Hereditary Spastic Paraplegia Woong-Woo LEE Korea
PO-0102 Clinical Profile of Meige Syndrome: A Rare Case Series Mutiara Aidha BETAVIANA Indonesia
PO-0103 A Case of Pure Autonomic Failure with Severe Neurogenic Bladder: An Evolution to Multiple System Atrophy Hyun Ah KIM Korea
PO-0104 A Case Report of Lewy Body Dementia with Positive Amyloid PET   Moon Ho PARK Korea
PO-0105 A Case of Concurrent Manifestations Including Acquired Chorea Associated with Polycythemia Vera Hyungseok HAH Korea
Parkinson’s Disease: Medical Treatment
PO-0106 Burning Mouth Syndrome as an Aftermath of Parkinson’s Disease D.A JOHNS India
PO-0107 Discovery of Novel Coumarin-pyrazole (CP-31) as Adenosine A2A Receptor Antagonist and MAO-B Inhibitor for Benefit in Parkinson’s Disease with Favorable Metabolic Profile Udaya P SINGH India
PO-0108 Parkinson’s Disease: The Challenges and the Future Zulfa SAUMIA Indonesia
PO-0109 Hesperidin Mitigates Angiogenesis in Rotenone Induced Nigrostriatal Neuronal Death via Activation of AMPK-FOXO3 Signaling Pathway Deepika SINGH India
PO-0110 Neuroprotective Role of Dimethyl Fumarate (DMF) through Enhanced Mitophagy via Nrf2/NRF1/BNIP3/PINK1 Axis in MPP+ Induced Parkinson’s Disease Mice Model Pushpa Tryphena KAMATHAM India
PO-0111 Activation of PI3K/AKT Signaling by Apremilast Reduces the Severity of Rotenone-induced Parkinson’s Disease in Rodents Manvendra SINGH India
PO-0112 The Role of Cell Replacement Therapy in Parkinson’s Disease Derizal DERIZAL Indonesia
Parkinson’s Disease: Motor Features
PO-0113 Motor Reserve and Progression of Parkinson Disease  Myung Jun LEE Korea
PO-0114 Can Gait Instability Indicate the Cognitive Function of People with Parkinson’s Disease? Juseon HWANG Korea
PO-0115 Detection of Parkinson’s Disease Using Body Segment Position-based Wearable Sensors and Artificial Intelligence during the Six-minute Walk Test Hyejin CHOI Korea
PO-0116 Fasting Plasma Glucose Level and Longitudinal Motor and Cognitive Outcomes in Parkinson’s Disease Ko-Eun CHOI Korea
PO-0117 Freezing of Gait is the Leading Cause of Falls in in Patients with Parkinson’s Disease in Korea Jinyoung YOUN Korea
PO-0118 Freezing of Gait is Associated to Postural Instability in Patients with Parkinson’s Disease in Korea Jinyoung YOUN Korea
Parkinson’s Disease: Non-medical, Surgical Treatment
PO-0119 Effects of High-intensity Interval Training and Moderate-intensity Continuous Training on Non-motor Symptoms in Patients with Parkinson’s Disease: A Randomized Pilot Trial Ryul KIM Korea
PO-0120 Effects of High-intensity Interval Training and Moderate-intensity Continuous Training on Sarcopenia-related Parameters in Patients with Parkinson’s Disease: A 24-week Randomized Pilot Trial Substudy  Ryul KIM Korea
PO-0121 Efficacy of Deep Brain Stimulation Versus High-intensity Focused Ultrasound of the Bilateral Subthalamic Nucleus in the Surgical Treatment of Parkinson’s Disease: A Meta-analysis Adrian Paul DE LEON Philippines
PO-0122 The Effect of Virtual Reality Rehabilitation Compared to Conventional Physical Therapy in Parkinson’s Disease Patients: A Systematic Review Ni Nyoman YULIANTINI Indonesia
PO-0123 Emergency Department Visits in Patients with Parkinson’s Disease with Deep Brain Stimulation Seungmin LEE Korea
PO-0124 The Effectiveness of Contactless, Virtual Exercise Intervention in Patients with Parkinson’s Disease: A Pilot Study Jeonghyun PARK Korea
PO-0125 Reduction in Mortality Rates Depending on the Duration of Rehabilitation in Patients with Parkinson’s Disease: A Nationwide Population-based Cohort Study Jong Woo LEE Korea
PO-0126 Two Weeks of Intensive Balance Training Improve Balance and Decrease Fall Risk in Parkinson’s Disease Patients Better than Conventional Approach Alexey ZIMIN Russian Federation
PO-0127 The Comparative Study of the Effect of Various Exercises on Symptoms in Parkinson’s Disease Jinse PARK Korea
PO-0128 Double ‘Electric’ Trouble; Deep Brain Stimulation in Patients with Pre-existing Cardiac Implantable Electronic Device: A Case Series and Review of Existing Literature Jongmok HA Korea
PO-0129 How Does Deep Brain Stimulation and Infusion Therapy Updates in Treatment of Parkinson’s Disease Ferza ALFATH Indonesia
Parkinson’s Disease: Nonmotor Features
PO-0130 The Clinical Phenotype of Psychiatric-onset Prodromal Dementia with Lewy Bodies: A Scoping Review Chaminda GUNAWARDANA Australia
PO-0131 Unveiling Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease-related Cognitive Impairment Joong-Seok KIM Korea
PO-0132 Treatment of Parkinson’s Disorders and Related Complication through Application of Bavachin in the Medicine: Biological Importance with Their Underline Molecular Mechanism Dinesh Kumar PATEL India
PO-0133 Scaling Dysfunction is Associated with Pain in Parkinson’s Disease Suk Yun KANG Korea
PO-0134 Subtype of Postural Instability and Gait Difficulties Associated with Stereopsis in Parkinson’s Disease Jungyeun LEE Korea
PO-0135 What does it Mean When the Happy Smells Come and Go? - UPSIT Odor Identification Status Correlates with Fluctuation of Non-motor Symptoms in Parkinson’s Disease - A Longitudinal Follow-up Pilot Study Hsin-Bei LEI Taiwan
PO-0136 Disease Progression in Parkinson's Disease Patients with Mild Cognitive Impairment: 5-year Longitudinal Study from the Early Parkinson's Disease Longitudinal Singapore (PALS) Cohort Xiao DENG Singapore
PO-0137 Impact of Dysautonomia on Memory in Newly Diagnosed Parkinson’s Disease Patients Kyum-Yil KWON Korea
PO-0138 Impact of Cognitive Impairments on Falls in Newly Diagnosed Parkinson’s Disease Kyum-Yil KWON Korea
PO-0139 Effects of Sleep Hygiene on Sleep Disturbance in Patients with Parkinsonism  Chan Young LEE Korea
PO-0140 Assessment of Malnutrition among Filipino Patients with Parkinson’s Disease Cherry Ann DURANTE Philippines
PO-0141 Association of Hourly Step Count and Heart Rate Variability in Patients with Early Parkinson’s Disease:  Analysis from PPMI Database Supriyo CHOUDHURY India
PO-0142 Dysregulation of TRP Channels in Parkinson’s Disease Induce Pain Suk Jun SONG Korea
PO-0143 Correlation of SCOPA-AUT and COMPASS-31 Score as Evaluation Tools of Autonomic Dysfunction in Parkinson’s Disease Christine Kathy Putri SARI Indonesia
PO-0144 Factors Related to Subjective Bladder Symptoms in Parkinson’s Disease Assessed with COMPASS-31 Questionnaire Margareth HILDARIA Indonesia
PO-0145 Comparing Olfactory Characteristics in Parkinson’s Disease and Drug-induced Parkinsonism: Using Propensity Score Matching Approach  In Hee KWAK Korea
PO-0146 Comparative Analysis of Montreal Cognitive Assessment Performance in Distinguishing Cognitive Impairment in Parkinson’s Disease: Age and Education-Adjusted Cutoffs versus Machine Learning Yun Joong KIM Korea
PO-0147 Association of Future Dementia Risk and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease Kyoungwon BAIK Korea
PO-0148 Clinical Relationship between MoCA and KDSQ in Patients with Parkinson’s Disease Moon Ho PARK Korea
PO-0149 Visual Hallucination Correlated with Cognition Network in Patients with Parkinson’s Disease Sangjin LEE Korea
PO-0150 Evaluation of Olfactory and Gustatory Function in Early-stage Parkinson’s Disease: Implication for Cognitive Association Jeongjae LEE Korea
PO-0151 A Longitudinal Study of Temporal Reproduction Abilities in Parkinson’s Disease Patients Tanisha MAJUMDAR India
PO-0152 Sticking to the Letters: A New Type of Punding? Su Hyeon HA Korea
PO-0153 Urodynamic Study between De novo Parkinson’s Disease with "Body-first" and "Brain-first" Suptype Min Seung KIM Korea
Parkinson’s Disease: Others
PO-0154 Knowledge of General Practitioner about Housing Management in Parkinson Disease Patient  Gilang Nispu SAPUTRA Indonesia
PO-0155 Abstract Withdrawn    
PO-0156 Biological Importance of Bavachinin from Psoralea Corylifolia L against Parkinson’s Disease through Their Inhibitory Potential on Human Monoamine Oxidase A (MAO-A) and Human Monoamine Oxidase B (MAO-B) Dinesh Kumar PATEL India
PO-0157 Tamoxifen in Breast Cancer and Risk of Parkinson’s Disease Brendan Jen-Wei TAN Singapore
PO-0158 Therapeutic Potential of Irisflorentin as an Anti-Parkinsonian Drug Candidate: Biological Importance of Flavonoidal Compounds in the Brain Disorders Dinesh Kumar PATEL India
PO-0159 Solid Lipid Nanoparticles of Revasterol Mitigates Oxidative Stress in Nigrostriatal Tissue and Neurobehavioral Characteristics in Rotenone Induced Rat Model of Parkinson Diseases D CHUAHAN India
PO-0160 Abstract Withdrawn    
PO-0161 Clonal Hematopoiesis with TET2 Mutation is Associated with Parkinson’s Disease Kyung Ah WOO Korea
PO-0162 Digital Aging, Mental Health Deterioration, and Risk Mitigation in the Indonesian Elderly with Parkinson Disease Rosinta Hotmaida Pebrianti PURBA Indonesia
PO-0163 Association between Novel GWAS Parkinson’s Disease Risk Variant rs9638616 and Altered Brain Structure and Function Thomas WELTON Singapore
PO-0164 Fabrication, Characterization of Ganodric Acid-Dextrin Nanoformulation against Parkinson’s Disease-induced Functional Damage in Rats via Inhibition of Caspase-3/Interleukins-6 and 1β Prakash BHATT India
PO-0165 Changes in Depression Score, Malondialdehyde Level, and Glutathione Level in Parkinson’s Patients after Probiotic Intervention: A Systematic Review and Meta-analysis Randomized Controlled Trials Rafik PRABOWO Indonesia
PO-0166 A Patient with Parkinson’s Disease Presented with Early Motor Fluctuation Sangmin PARK Korea
PO-0167 Mediating Effect of Hip Fractures on All-cause Mortality in Adults with Parkinson’s Disease: A Nationwide Population-based Cohort Study Jong Woo LEE Korea
PO-0168 Bone Mineral Density in Early Parkinson’s Disease: Correlations with Disease Severity and Prognosis Hyae Lee YOU Korea
PO-0169 No Association between Anemia and Risk of Parkinson’s Disease: Evidence from a Meta-analysis Using Real-world Evidence Sidra ZAYED India
PO-0170 Association between Spinal Fractures and All-cause Mortality in Adults with Parkinson’s Disease: A Nationwide Population-based Cohort Study Yeonju JIN Korea
PO-0171 A Qualitative Evaluation of Parkinson Disease Patients Preference on Immediate and Extended Release Pramipexole Formulation in a Secondary Health Facility in Malaysia Sutha RAJAKUMAR Malaysia
PO-0172 Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link? A Meta-analysis Sanjeev KHAREL Nepal
PO-0173 A Case Report of an Elderly Male with Parkinson’s Disease and a History of Mild COVID 19 Infection Developing Creutzfeldt Jakob Disease Fallen Grace DE LA PAZ Philippines
PO-0174 Discovery of Potential Compound as Abelson Protein Inhibitor, a Promising Targeted Therapy Strategy for Parkinson’s Disease: Molecular Docking and Computational Screening Rizki Rachmad SAPUTRA Indonesia
PO-0175 Automated Differentation of Multiple System Atrophy-parkinsonian Type and Progressive Supranuclear Palsy on Susceptibility-weighted Imaging Using a Few-shot Machine Learning Model WonJune CHOI Korea
PO-0176 The Effects of Aquatic Watsu Therapy on Trunk Mobility in Patients with Parkinson's Disease Ana Paula LOUREIRO Brazil
PO-0177 Significant Association between Insulin Resistance and Survival in Parkinson’s Disease Patients Javad ALIZARGAR Iran, Islamic Republic of
PO-0178 Correlations between Skin Elasticity and Disease Severity in Patients with Parkinson’s Disease: A Preliminary Investigation Sooyeoun YOU Korea
PO-0179 Diagnostic Challenges of Patients with Korean De novo Parkinson’s Disease: Analysis of Diagnostic Patterns Hwa Been YANG Korea
PO-0180 Association between Urate Levels, Dopamine, and Motor Deficits in REM Sleep Behavior Disorder Jin Ho JUNG Korea
PO-0181 Correlation of Indonesian Version of Scopa-cog and Cdrs Scores in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia Abraham AL JODY Indonesia
PO-0182 Description of Knowledge of the General Public about Parkinson’s Disease in Indonesia Grace KEREN Indonesia
PO-0183 Temporal Microbiome Changes and Pathogenic Mechanisms in Parkinson’s Disease with Premotor RBD Sungyang JO Korea
PO-0184 Individual Motor Control of Fingers and Finger Flexion Strength in Parkinson’s Disease and Spinocerebellar Ataxia Type 12 Patients Suchismita MAJUMDAR India
PO-0185 Awareness of Parkinson’ Disease and Information Needs in Patients Kyung Joon JO Korea
PO-0186 Quality of Life in Parkinson Disease Patients: Systematics Reviews Mega Dwi SEPTIVANI Indonesia
PO-0187 Development of a 9-item Screening Questionnaire for Parkinsonism Dallah YOO Korea
PO-0188 Abstract Withdrawn    
PO-0189 Parkinson’s Disease and Potential Treatment : Case Study in Asia  Vivi USMAYANTI Indonesia
PO-0190 Moyamoya Disease and Risk of Parkinson Disease in Korea Dallah YOO Korea
Parkinsonism (Secondary and Parkinsonism-plus)
PO-0191 A Rare Cause of ‘Atypical Parkinsonism’- Cannot Afford to Miss Sheetal GOYAL India
PO-0192 Plethora of Symptoms: A Case Report on MSA-Cerebellar Type with Overlapping Progressive Muscular Atrophy Features and Genetic Results of ERBB4 ALS Variant Enrique Lorenzo PANGANIBAN Philippines
PO-0193 Parkinsonism after Carbon Monoxide Poisoning: A Case Report Bolortsetseg BATSAIKHAN Mongolia
PO-0194 A Case of Multiple System Atrophy in Mongolia Nomindalai BATBOLD Mongolia
PO-0195 A Case with a TWNK Variant in Young-onset Parkinsonism Yoonjeong NA Korea
PO-0196 Parkinsonism as a Presentation of Occipito-Atlantoaxial Compression in a 70 Year Old Female  Patricia Fleur ANDAYA Philippines
PO-0197 Neuropathological Characteristics of Progressive Supranuclear Palsy Presenting as Clinical Corticobasal Syndrome Hankyu LEE Korea
PO-0198 Toward a Clinically Usable Score Using Gut Microbiome Signature in Multiple System Atrophy Identified by Multi-modal Analyses Ming-Che KUO Taiwan
PO-0199 Clinical Characteristics Differentiating the Subtypes of Multiple System Atrophy (MSA) Jihyun LEE Korea
PO-0200 Study of Correlation between Timed Up and Go (TUG), Dynamic Gait Index (DGI), Fall Efficacy Scale International (FES-I) in Patients with Parkinsonism Rosy NEUPANE India
Technologies and AI for Movement Disorder
PO-0201 Deep Brain Stimulation Programming Techniques for Gait Problems in X-Linked Dystonia Parkinsonism: A Comparative Analysis of Cases Renato GALVAN Philippines
PO-0202 Deep Learning Model for the Parkinson’s Disease Screening during Polysomnography Min Seok BAEK Korea
PO-0203 Regional Brain Atrophy in Patients with Dentatorubral Pallidoluysian Atrophy Myung Ki YOON Korea
PO-0204 A Deep Learning Approach to Access Parkinson’s Disease Using Static Balance Characteristics Dawoon JUNG Korea
PO-0205 Machine Learning Algorithms for the PD Prescreening based on Mobile Cardiac Telemetry Platform Min Seok BAEK Korea
PO-0206 Vision-based Spatiotemporal Gait Parameters Estimation in Parkinson’s Disease Patients Using a Single Camera and a CNN-Transformer Hybrid Network Ankhzaya JAMSRANDORJ Korea
PO-0207 Can Chat GPT Aid in the Diagnosis of Rare Movement Disorders? Pan-Woo KO Korea
PO-0208 Vagus Nerve Cross-sectional Area Decreases even in Early-stage Parkinson’s Disease Patients Hyung-Soo LEE Korea
PO-0209 Optimal Measuring Height and Validation of 2D-LiDAR Based Analysis System for Spatiotemporal Gait Parameters Chaewon SHIN Korea
PO-0210 Distinguishing Parkinson’s Disease from Atypical Parkinsonian Syndrome Using Multistage Deep Learning based on Dopamine Transporter Imaging Chakraborty SABYASACHI Korea
PO-0211 Gait during Turning Associates with Imbalance and Falls in PD: 3D Video Based Analysis from a Single Camera HoYoung JEON Korea
PO-0212 Bilateral Hypertrophic Olivary Degeneration in Symptomatic Palatal Tremor Jia Haur THO Malaysia
PO-0213 The Link between Essential Tremor and Parkinson’s Disease  Sang-Won YOO Korea
PO-0214 A Case of Task-specific Hand Tremor while Driving Minkyeong KIM Korea
PO-0215 Position-specific Tremor and Limb Ataxia after Infratentorial Arteriovenous Malformation Rupture in Neurofibromatosis Type 1 Patient Eunbuel KO Korea
PO-0216 Impact on Sensory Pathway and Balance Stability after Magnetic Resonance-guided Focused Ultrasound Thalamotomy in Patients with Tremor  Sheng-Chieh LIN Taiwan
PO-0217 Electrophysiological Features of Tremor in Parkinson’s Disease  In Ja SHIN Korea
PO-0218 Early Onset Progressive Holmes Tremor due to Ischemic Stroke: A Rare Case Report Aqmarina RAKHMAWATI Indonesia
PO-0219 Quantification of Tremor Dynamics via Video-based Analysis Seung-Hwan LEE Korea